Comparative Study of Paraneoplastic and Nonparaneoplastic Autoimmune Encephalitis With GABA B R Antibodies
Authors:
- Florian LamblinFLFlorian Lamblin
- Jeroen KerstensJKJeroen Kerstens
- Sergio Muñiz-CastrilloSMSergio Muñiz-Castrillo
- Alberto VogrigAVAlberto Vogrig
- David GoncalvesDGDavid Goncalves
- Veronique RogemondVRVeronique Rogemond
- Geraldine PicardGPGeraldine Picard
- Marine VillardMVMarine Villard
- Anne-Laurie PintoAPAnne-Laurie Pinto
- Marleen H. Van Coevorden-HameeteMCMarleen H. Van Coevorden-Hameete
- Marienke A. De BruijnMBMarienke A. De Bruijn
- Juna M. De VriesJVJuna M. De Vries
Open Access
- 1 May 2024
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology Neuroimmunology & Neuroinflammation
- Vol. 11 (3) , e200229
Abstract
While patients with paraneoplastic autoimmune encephalitis (AE) with gamma-aminobutyric-acid B receptor antibodies (GABABR-AE) have poor functional outcomes and high mortality, the prognosis of nonparaneoplastic cases has not been well studied. Patients with GABABR-AE from the French and the Dutch Paraneoplastic Neurologic Syndromes Reference Centers databases were retrospectively included and their data collected; the neurologic outcomes of paraneoplastic and nonparaneoplastic cases were compared. Immunoglobulin G (IgG) isotyping and human leukocyte antigen (HLA) genotyping were performed in patients with available samples. A total of 111 patients (44/111 [40%] women) were enrolled, including 84 of 111 (76%) paraneoplastic and 18 of 111 (16%) nonparaneoplastic cases (cancer status was undetermined for 9 patients). Patients presented with seizures (88/111 [79%]), cognitive impairment (54/111 [49%]), and/or behavioral disorders (34/111 [31%]), and 54 of 111 (50%) were admitted in intensive care unit (ICU). Nonparaneoplastic patients were significantly younger (median age 54 years [range 19-88] vs 67 years [range 50-85] for paraneoplastic cases, p < 0.001) and showed a different demographic distribution. Nonparaneoplastic patients more often had CSF pleocytosis (17/17 [100%] vs 58/78 [74%], p = 0.02), were almost never associated with KTCD16-abs (1/16 [6%] vs 61/70 [87%], p < 0.001), and were more frequently treated with second-line immunotherapy (11/18 [61%] vs 18/82 [22%], p = 0.003). However, no difference of IgG subclass or HLA association was observed, although sample size was small (10 and 26 patients, respectively). After treatment, neurologic outcome was favorable (mRS ≤2) for 13 of 16 (81%) nonparaneoplastic and 37 of 84 (48%) paraneoplastic cases (p = 0.03), while 3 of 18 (17%) and 42 of 83 (51%) patients had died at last follow-up (p = 0.008), respectively. Neurologic outcome no longer differed after adjustment for confounding factors but seemed to be negatively associated with increased age and ICU admission. A better survival was associated with nonparaneoplastic cases, a younger age, and the use of immunosuppressive drugs. Nonparaneoplastic GABABR-AE involved younger patients without associated KCTD16-abs and carried better neurologic and vital prognoses than paraneoplastic GABABR-AE, which might be due to a more intensive treatment strategy. A better understanding of immunologic mechanisms underlying both forms is needed.Keywords
This publication has 37 references indexed in Scilit:
- Comparison of the clinical syndromes of anti-GABAa versus anti-GABAb associated autoimmune encephalitis: A systematic reviewJournal of Neuroimmunology, 2022
- Anti‐LGI1, anti‐GABABR, and Anti‐CASPR2 encephalitides in Asia: A systematic reviewBrain and Behavior, 2020
- Clinical characteristics and long-term follow-up of seven cases of anti-GABABR encephalitis in patients of Han Chinese descentNeurological Sciences, 2019
- Isolated seizures are a common early feature of paraneoplastic anti-GABAB receptor encephalitisJournal of Neurology, 2018
- Genetic alterations and tumor immune attack in Yo paraneoplastic cerebellar degenerationActa Neuropathologica, 2018
- Anti‐LGI1 encephalitis is strongly associated with HLA‐DR7 and HLA‐DRB4Annals of Neurology, 2017
- Anti‐LGI1 encephalitis is associated with unique HLA subtypesAnnals of Neurology, 2016
- A clinical approach to diagnosis of autoimmune encephalitisThe Lancet Neurology, 2016
- Antibodies to the GABAB receptor in limbic encephalitis with seizures: case series and characterisation of the antigenThe Lancet Neurology, 2010
- The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studiesThe Lancet, 2007